Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro de Pablos-Velasco

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Expert Review of Cardiovascular Therapy|July 31, 2010
Pioglitazone: beyond glucose controlPedro de Pablos-Velasco
Revista Espanola De Cardiologia|November 13, 2008
[Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study]Vivencio Barrios, Ricardo Gómez-Huelgas, Rosario Rodríguez, et al.
Diabetes Care|April 30, 2003
The relation between physical activity and metabolic control in type 2 diabetes with <20 years of evolutionPedro de Pablos-Velasco, Wilfredo Ricart, Susana Monereo, et al.
Public Health Nutrition|November 21, 2007
Obesity and cardiovascular diseaseAntonio Pérez Pérez, Juan Ybarra Muñoz, Vicente Blay Cortés, et al.
Minerva Endocrinologica|March 7, 2017
Pancreatic beta cell function is preserved in the short term in patients with type 2 diabetes undergoing non-urgent surgeryGema Hernanz-Rodriguez, Pablo Pedrianes-Martin, Pedro de Pablos-Velasco, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 29, 2014
Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic optionRicardo Gómez-Huelgas, Sharona Azriel, Manel Puig-Domingo, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 20, 2010
Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease durationJosé M Miralles-García, Pedro de Pablos-Velasco, Lucio Cabrerizo, et al.
Diabetes Care|November 28, 2002
Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic populationCarola Saloranta, Christiane Guitard, Eckhard Pecher, et al.
Primary Care Diabetes|July 15, 2011
PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study designClare Bradley, Pedro de Pablos-Velasco, Klaus G Parhofer, et al.
Journal of Hypertension|October 3, 2002
Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guía StudyPedro de Pablos-Velasco, Francisco Javier Martínez-Martín, Fátima Rodríguez Pérez, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Expert Review of Cardiovascular Therapy|July 31, 2010
Pioglitazone: beyond glucose controlPedro de Pablos-Velasco
Revista Espanola De Cardiologia|November 13, 2008
[Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study]Vivencio Barrios, Ricardo Gómez-Huelgas, Rosario Rodríguez, et al.
Diabetes Care|April 30, 2003
The relation between physical activity and metabolic control in type 2 diabetes with <20 years of evolutionPedro de Pablos-Velasco, Wilfredo Ricart, Susana Monereo, et al.
Public Health Nutrition|November 21, 2007
Obesity and cardiovascular diseaseAntonio Pérez Pérez, Juan Ybarra Muñoz, Vicente Blay Cortés, et al.
Minerva Endocrinologica|March 7, 2017
Pancreatic beta cell function is preserved in the short term in patients with type 2 diabetes undergoing non-urgent surgeryGema Hernanz-Rodriguez, Pablo Pedrianes-Martin, Pedro de Pablos-Velasco, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 29, 2014
Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic optionRicardo Gómez-Huelgas, Sharona Azriel, Manel Puig-Domingo, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 20, 2010
Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease durationJosé M Miralles-García, Pedro de Pablos-Velasco, Lucio Cabrerizo, et al.
Diabetes Care|November 28, 2002
Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic populationCarola Saloranta, Christiane Guitard, Eckhard Pecher, et al.
Primary Care Diabetes|July 15, 2011
PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study designClare Bradley, Pedro de Pablos-Velasco, Klaus G Parhofer, et al.
Journal of Hypertension|October 3, 2002
Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guía StudyPedro de Pablos-Velasco, Francisco Javier Martínez-Martín, Fátima Rodríguez Pérez, et al.
Pageof 5